OBJECTIVES: Because of the large number of cases of visceral leishmaniasis (VL) recorded in Brazil over the last few years, this disease has been showing characteristics different from previously known ones. We report cases of pregnant women treated for VL, describing their course and outcome and the chemotherapeutic medication used according to the clinical signs and symptoms of each patient. STUDY DESIGN: We report five cases of pregnant women treated for VL in a central-western region of Brazil. RESULTS: No case of vertical transmission was observed, even in patients who were treated after delivery. One of the patients with a late diagnosis made after the onset of symptoms died. Thus, the treatment of VL during pregnancy reduces maternal mortality and the rate of vertical transmission of the disease, being safe and effective as long as the disease is diagnosed early. CONCLUSION: At present, amphotericin B and its derivatives appear to be the best therapeutic option for the mother-child binomial.
OBJECTIVES: Because of the large number of cases of visceral leishmaniasis (VL) recorded in Brazil over the last few years, this disease has been showing characteristics different from previously known ones. We report cases of pregnant women treated for VL, describing their course and outcome and the chemotherapeutic medication used according to the clinical signs and symptoms of each patient. STUDY DESIGN: We report five cases of pregnant women treated for VL in a central-western region of Brazil. RESULTS: No case of vertical transmission was observed, even in patients who were treated after delivery. One of the patients with a late diagnosis made after the onset of symptoms died. Thus, the treatment of VL during pregnancy reduces maternal mortality and the rate of vertical transmission of the disease, being safe and effective as long as the disease is diagnosed early. CONCLUSION: At present, amphotericin B and its derivatives appear to be the best therapeutic option for the mother-child binomial.
Authors: Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo Journal: Drug Dev Res Date: 2011-09 Impact factor: 4.360
Authors: Susanne U Franssen; Mandy J Sanders; Matt Berriman; Christine A Petersen; James A Cotton Journal: Emerg Infect Dis Date: 2022-06 Impact factor: 16.126
Authors: Kazi Mizanur Rahman; Anna Olsen; David Harley; Colin D Butler; Dinesh Mondal; Stephen P Luby; Adrian C Sleigh Journal: PLoS Negl Trop Dis Date: 2014-05-01
Authors: Rafaianne Q Moraes-Souza; Ana Paula Reinaque; Thaigra S Soares; Ana Luiza T Silva; Rodolfo C Giunchetti; Maria A S Takano; Milena A Akamatsu; Flávia S Kubrusly; Fernanda Lúcio-Macarini; Isaias Raw; Dmitri Iourtov; Paulo Lee Ho; Lilian L Bueno; Ricardo T Fujiwara; Gustavo T Volpato Journal: PLoS One Date: 2017-03-01 Impact factor: 3.240